CPI-1189

DRUG2 trials

Sponsors

Centaur Pharmaceuticals

Conditions

AIDS Dementia ComplexHIV Infections

Phase 1

Safety and Effectiveness of CPI-1189 in HIV-Infected Males on Combination Anti-HIV Drug Therapy

CompletedNCT00002209

Centaur PharmaceuticalsAIDS Dementia Complex, HIV Infections

Target: 48Updated: 2005-06-24

Phase 2

Safety and Effectiveness of Giving CPI-1189 to HIV-Infected Patients With AIDS Dementia

Centaur PharmaceuticalsHIV Infections

Target: 60Updated: 2005-06-24